Skip to main content
. 2014 Mar 27:269–289. doi: 10.1533/9781845697198.2.269

Table 10.4.

Recent in vivo studies on the efficacy of orally administered immunoglobulin preparations on health

Antigen used in immunization Disease or condition Treatment regimen Treatment effect Reference
S. mutans and S. sobrinus whole cell vaccine Dental caries Mouth rinse 3 times daily for 3 days (human volunteers) Higher resting pH and smaller proportion of S. mutans in dental plaque Loimaranta et al. (1999)
Virulence factors of S. mutans Dental caries Mouth rinse twice per day for 14 days by 10 ml of immune milk (human volunteers) Inhibited recolonization of S. mutans after antibiotic treatment Shimazaki et al. (2001)
Helicobacter feliswhole cell vaccine Gastritis 0.2 ml of immune whey (7.5% IgG) before infection or 3 times daily for 4 weeks in treatment of infected mice Prevented infection in non-infected mice and decreased gastric inflammation and colonization in readily infected mice Marnila et al. (2003)
Helicobacter pyloriurease Gastritis 150 ml of yogurt with 1% avian IgY and probiotic bacteria 3 times daily for 4 weeks Decreased values in urea breath test indicating decrease in colonization Horie et al. (2004)
No immunization EHEC-colitis Colostral preparation IMMULACT® to mice ad libitum (around 300 mg per day) for 3 weeks Decreased rapidly EHEC colonization and decresed attachment to cecum walls and decreased mortality in mouse Funatogawa et al. (2002)
Polyvalent or monovalent E. coli vaccine Diarrhea IgG supplemented baby formula, daily dose 0.5 g of IgG per kg of body weight Lower incidence of diarrhea and shorter duration of diarrhea episodes in human infants during follow-up period for 6 months Tawfeek et al. (2003)
Shigella dysenteriaeantigen I Shigellosis 100 ml orally 3 times per day for 3 days in combination with antibiotics No significant difference in any clinical parameter Ashraf et al. (2001)
No immunization HIV-associated diarrhea Colostral preparation ColoPlus® to HIV-associated diarrhea patients for 7 weeks Substantial decrease in stool frequency and in fatigue and increase in body weight Florén et al. (2006)
Cocktail of 17 strains of pathogenic diarrhea bacteria E. coli and Salmonella diarrhea Orally 10 mg of specific Ig per day for 10 days starting 6 or 8 days before infection Prevented enteroinvasive E. coli and Salmonella typhi diarrhea and normalized immunological parameters Xu et al. (2006)
Cocktail of 17 strains of pathogenic diarrhea bacteria E. coli, Salmonella and Shigella diarrhea Orally once per day for 10 days starting 6 or 8 days before infection Decreased the clinical signs of diarrhea and supported splenic NK-cell functions Huang et al. (2008)
No immunization Murine rotavirus infection in mouse Milk IgG fraction orally at time of infection and 12 hours post infection Decreases rotavirus shedding in stools Bojsen et al. (2007)
Clostridium difficile toxin and C. difficile whole cells C. difficile diarrhea Orally for 2 weeks as supportive treatment after antibiotic treatment C. difficile toxins eradicated from 15 of 16 patients and no relapses in any patient during 11-month follow-up period Van Dissel et al. (2005)
No immunization Mild hypercholesterolemia Orally 5 g of blood derived IgG daily for 3 or 6 weeks Both total cholesterol and LDL levels decreased from baselines Earnest et al. (2005)
No immunization Upper respiratory tract infections 60 g of colostral protein daily for 8 weeks Reduced significantly incidence of self-estimated symptoms of respiratory infections but no difference in duration Brinkworth and Buckley (2003)
No immunization Endotoxemia due to abdominal surgery Colostral product Lactobin® 52 g daily in 4 doses orally for 3 days before surgery Lower levels of endotoxin and endotoxin neutralizing capacity in blood suggesting reduced endotoxemia due to surgery Bölke et al. (2002a)
No immunization Endotoxemia due to coronary surgery Colostral product Lactobin® 42 g daily doses orally for 2 days before surgery Lower levels of CRP but no effect on perioperative endotoxemia Bölke et al. (2002b)

Parts of this table compiled and edited from Korhonen et al. (2000) and Mehra et al.. (2006).